480 related articles for article (PubMed ID: 24582992)
1. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
[TBL] [Abstract][Full Text] [Related]
2. Orbital Radiotherapy Combined With Corticosteroid Treatment for Thyroid Eye Disease-Compressive Optic Neuropathy.
Gold KG; Scofield S; Isaacson SR; Stewart MW; Kazim M
Ophthalmic Plast Reconstr Surg; 2018; 34(2):172-177. PubMed ID: 29517594
[TBL] [Abstract][Full Text] [Related]
3. Low dose orbital radiotherapy for thyroid eye disease.
Li Yim JF; Sandinha T; Kerr JM; Ritchie D; Kemp EG
Orbit; 2011 Dec; 30(6):269-74. PubMed ID: 22132844
[TBL] [Abstract][Full Text] [Related]
4. Transcaruncular orbital decompression: an alternate procedure for Graves ophthalmopathy with compressive optic neuropathy.
Liao SL; Chang TC; Lin LL
Am J Ophthalmol; 2006 May; 141(5):810-818. PubMed ID: 16527228
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy for Active Thyroid Eye Disease.
Godfrey KJ; Kazim M
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S98-S104. PubMed ID: 29771752
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
[TBL] [Abstract][Full Text] [Related]
8. Orbital radiotherapy for thyroid eye disease.
Dolman PJ; Rath S
Curr Opin Ophthalmol; 2012 Sep; 23(5):427-32. PubMed ID: 22729183
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
10. [Radiation therapy for thyroid-associated ophthalmopathy].
Luo QL; He WM; Tang L; Chen LJ
Zhonghua Yan Ke Za Zhi; 2006 Mar; 42(3):218-21. PubMed ID: 16643752
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of combined immunosuppression and orbital radiotherapy in thyroid-related restrictive myopathy: two-center experience.
Chalvatzis NT; Tzamalis AK; Kalantzis GK; El-Hindy N; Dimitrakos SA; Potts MJ
Eur J Ophthalmol; 2014; 24(6):953-9. PubMed ID: 24706350
[TBL] [Abstract][Full Text] [Related]
12. [Development of ocular motility following modified 3-wall decompression of the orbita in endocrine orbitopathy for functional and rehabilitative indication].
Grenzebach UH; Schnorbus U; Büchner T; Busse H; Stoll W
Klin Monbl Augenheilkd; 2003 May; 220(5):345-51. PubMed ID: 12766824
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.
Zoumalan CI; Cockerham KP; Turbin RE; Volpe NJ; Kazim M; Douglas RS; Feldon SE
J Neuroophthalmol; 2007 Sep; 27(3):205-14. PubMed ID: 17895822
[TBL] [Abstract][Full Text] [Related]
14. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
Juri J; Stiglmayer N; Kuzman T
Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
[TBL] [Abstract][Full Text] [Related]
15. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
Ng CM; Yuen HK; Choi KL; Chan MK; Yuen KT; Ng YW; Tiu SC
Hong Kong Med J; 2005 Oct; 11(5):322-30. PubMed ID: 16219950
[TBL] [Abstract][Full Text] [Related]
16. Ocular Hypertension, Glaucoma or Compressive Neuropathy in Patient with Active TED.
Stoyanova NS; Konareva-Kostianeva MI; Mitkova-Hristova VT
Folia Med (Plovdiv); 2020 Jun; 62(2):418-423. PubMed ID: 32666771
[TBL] [Abstract][Full Text] [Related]
17. Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease.
Claridge KG; Ghabrial R; Davis G; Tomlinson M; Goodman S; Harrad RA; Potts MJ
Eye (Lond); 1997; 11 ( Pt 5)():717-22. PubMed ID: 9474324
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic and transconjunctival orbital decompression for thyroid-related orbital apex compression.
Schaefer SD; Soliemanzadeh P; Della Rocca DA; Yoo GP; Maher EA; Milite JP; Della Rocca RC
Laryngoscope; 2003 Mar; 113(3):508-13. PubMed ID: 12616205
[TBL] [Abstract][Full Text] [Related]
19. Orbital decompression in Graves' orbitopathy: efficacy and safety.
Goh MS; McNab AA
Intern Med J; 2005 Oct; 35(10):586-91. PubMed ID: 16207257
[TBL] [Abstract][Full Text] [Related]
20. Orbital Radiation for Thyroid Eye Disease: A Report by the American Academy of Ophthalmology.
Sobel RK; Aakalu VK; Vagefi MR; Foster JA; Tao JP; Freitag SK; Wladis EJ; McCulley TJ; Yen MT
Ophthalmology; 2022 Apr; 129(4):450-455. PubMed ID: 34895729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
